AI
INSM icon

Axiom Investors’s Insmed INSM Stock Holding History

Axiom Investors’s Portfolio INSM Stock Details INSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-239,447
Closed -$39.2M – 139
2026
Q1 		$39.2M Sell
239,447
-16,402
-6% -$2.52M 0.44% 31
2025
Q4 		$44.5M Buy
255,849
+148,116
+137% +$27M 0.39% 34
2025
Q3 		$15.5M Buy
107,733
+46,992
+77% +$5.76M 0.11% 72
2025
Q2 		$6.11M Sell
60,741
-19,184
-24% -$1.47M 0.05% 94
2025
Q1 		$6.1M Sell
79,925
-3,949
-5% -$302K 0.06% 94
2024
Q4 		$5.79M Sell
83,874
-3,340
-4% -$241K 0.04% 108
2024
Q3 		$6.37M Sell
87,214
-38,384
-31% -$2.83M 0.06% 101
2024
Q2 		$8.42M Buy
125,598
+61,547
+96% +$2.39M 0.07% 85
2024
Q1 		$1.74M Buy
64,051
+4,024
+7% +$113K 0.02% 130
2023
Q4 		$1.86M Buy
+60,027
New +$1.56M 0.02% 122

Other funds holding INSM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return

Axiom Investors's INSM Position: Q2 2026 in Review

Axiom Investors sold out of Insmed (INSM) in Q2 2026, closing a stake of 239,447 shares — an estimated $39.2M sold.

Axiom Investors first reported a position in INSM in Q4 2023 and held it in 10 quarters. The position peaked at $44.5M in Q4 2025. 667 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

  • Axiom Investors reported no remaining Insmed position as of Q2 2026 after selling out during the quarter.
  • Axiom Investors sold 239,447 Insmed shares in Q2 2026, an estimated $39.2M.
  • Axiom Investors first reported a position in Insmed in Q4 2023 and held it in 10 quarters.
  • Axiom Investors's Insmed position peaked at $44.5M in Q4 2025.
  • 667 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on Axiom Investors's 13F filing for Q2 2026, filed 12 Aug 2026.